KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Retained Earnings: 2009-2024

Historic Retained Earnings for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $1.8 billion.

  • Charles River Laboratories International's Retained Earnings fell 8.41% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 8.41%. This contributed to the annual value of $1.8 billion for FY2024, which is 3.98% down from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Retained Earnings is $1.8 billion, which was down 3.98% from $1.9 billion recorded in FY2023.
  • Charles River Laboratories International's 5-year Retained Earnings high stood at $1.9 billion for FY2023, and its period low was $625.4 million during FY2020.
  • For the 3-year period, Charles River Laboratories International's Retained Earnings averaged around $1.7 billion, with its median value being $1.8 billion (2024).
  • Per our database at Business Quant, Charles River Laboratories International's Retained Earnings skyrocketed by 123.10% in 2020 and then decreased by 3.98% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Retained Earnings stood at $625.4 million in 2020, then spiked by 56.82% to $980.8 million in 2021, then soared by 46.10% to $1.4 billion in 2022, then skyrocketed by 31.71% to $1.9 billion in 2023, then declined by 3.98% to $1.8 billion in 2024.